Delivery Order SPE2DX22D0010-SPE2D825FJH55
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of Concerta ER 36 mg tablets (100 count) valued at $17,812.02. This competitively awarded, firm fixed-price delivery order has a completion date of September 11, 2025, and represents a child contract under the Defense Logistics Agency's broader pharmaceutical supply framework. The contract type and compressed timeline indicate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a contract ceiling value of $11,539.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for the supply of Concerta ER 36 mg tablets (100 count units) with a ceiling value of $4,310.92. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 5, 2025. The award fulfills the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $5,783.47, with delivery completion by September 10, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime contractor, headquartered in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $31,857.38 to AmerisourceBergen Drug Corp for 36mg Concerta ER tablets on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Concerta ER (Extended Release) tablets 36 mg. This firm fixed-price delivery order, valued at approximately $42.9K, represents a non-competitive award under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. The contract is scheduled for completion by August 1, 2025, with fulfillment occurring at...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,325.78 on August 5, 2025, for the supply of Concerta ER 36 mg tablets (100 count). This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-competitive set-aside contract executed under AmerisourceBergen's existing federal contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $47,631.00 for 100 tablets of Concerta ER 54 mg on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price, competitively awarded contract (with no set-aside designation) represents a pharmaceutical supply delivery under the company's existing DLA contract vehicle. The medication will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $2,021.76. This non-set-aside, competitively awarded contract operates under firm fixed pricing and is classified as a delivery order with an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania....
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJH55Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $15,818.06. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and involves no set-aside designation. The award was made competitively and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse medical supply requirements across multiple therapeutic domains, positioning it as a primary vendor for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 9/12/25 |